CVS Health Free Cash Flow 2010-2023 | CVS
CVS Health annual/quarterly free cash flow history and growth rate from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- CVS Health free cash flow for the quarter ending December 31, 2023 was 10,395.00, a year-over-year.
- CVS Health free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- CVS Health annual free cash flow for 2023 was $10.395B, a 22.71% decline from 2022.
- CVS Health annual free cash flow for 2022 was $13.45B, a 14.58% decline from 2021.
- CVS Health annual free cash flow for 2021 was $15.745B, a 17.25% increase from 2020.
| CVS Health Annual Free Cash Flow |
| 2023 |
10,395.00 |
| 2022 |
13,450.00 |
| 2021 |
15,745.00 |
| 2020 |
13,428.00 |
| 2019 |
10,391.00 |
| 2018 |
6,828.00 |
| 2017 |
6,089.00 |
| 2016 |
7,917.00 |
| 2015 |
6,207.00 |
| 2014 |
6,012.00 |
| 2013 |
3,853.00 |
| 2012 |
4,664.00 |
| 2011 |
3,988.00 |
| 2010 |
2,808.00 |
| 2009 |
1,510.00 |
| CVS Health Quarterly Free Cash Flow |
| 2023-12-31 |
10,395.00 |
| 2023-09-30 |
13,942.00 |
| 2023-06-30 |
11,771.00 |
| 2023-03-31 |
6,454.00 |
| 2022-12-31 |
13,450.00 |
| 2022-09-30 |
16,090.00 |
| 2022-06-30 |
7,547.00 |
| 2022-03-31 |
2,512.00 |
| 2021-12-31 |
15,745.00 |
| 2021-09-30 |
12,337.00 |
| 2021-06-30 |
7,424.00 |
| 2021-03-31 |
2,063.00 |
| 2020-12-31 |
13,428.00 |
| 2020-09-30 |
10,574.00 |
| 2020-06-30 |
9,234.00 |
| 2020-03-31 |
2,563.00 |
| 2019-12-31 |
10,391.00 |
| 2019-09-30 |
8,324.00 |
| 2019-06-30 |
5,997.00 |
| 2019-03-31 |
1,232.00 |
| 2018-12-31 |
6,828.00 |
| 2018-09-30 |
4,934.00 |
| 2018-06-30 |
4,377.00 |
| 2018-03-31 |
1,873.00 |
| 2017-12-31 |
6,089.00 |
| 2017-09-30 |
6,751.00 |
| 2017-06-30 |
4,657.00 |
| 2017-03-31 |
3,081.00 |
| 2016-12-31 |
7,917.00 |
| 2016-09-30 |
6,435.00 |
| 2016-06-30 |
2,995.00 |
| 2016-03-31 |
1,843.00 |
| 2015-12-31 |
6,207.00 |
| 2015-09-30 |
3,379.00 |
| 2015-06-30 |
2,093.00 |
| 2015-03-31 |
1,573.00 |
| 2014-12-31 |
6,012.00 |
| 2014-09-30 |
3,286.00 |
| 2014-06-30 |
2,185.00 |
| 2014-03-31 |
1,789.00 |
| 2013-12-31 |
3,853.00 |
| 2013-09-30 |
2,928.00 |
| 2013-06-30 |
1,749.00 |
| 2013-03-31 |
1,327.00 |
| 2012-12-31 |
4,664.00 |
| 2012-09-30 |
3,626.00 |
| 2012-06-30 |
3,199.00 |
| 2012-03-31 |
2,410.00 |
| 2011-12-31 |
3,988.00 |
| 2011-09-30 |
3,868.00 |
| 2011-06-30 |
2,363.00 |
| 2011-03-31 |
1,569.00 |
| 2010-12-31 |
2,808.00 |
| 2010-09-30 |
1,625.00 |
| 2010-06-30 |
846.00 |
| 2010-03-31 |
659.00 |
| 2009-12-31 |
1,510.00 |
| 2009-09-30 |
478.00 |
| 2009-06-30 |
232.00 |
| 2009-03-31 |
305.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$70.301B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
